If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
385.00    0.00 (0.00%)
Bid:
370.00
Ask:
400.00
Spread: 30.00 (8.108%)
Market Cap: £36.79m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Trading Update

8 Mar 2021 07:00

RNS Number : 4015R
Cropper(James) PLC
08 March 2021
 

Cropper(James) PLC

 

8 March 2021

James Cropper plc ("James Cropper" or the "Company")

Trading update

 

James Cropper PLC, the advanced materials and paper products group, is pleased to issue a positive trading update for the 52 weeks to 27 March 2021.

As reported in the half year results to 26 September 2020, the first half of the year had been particularly challenging due to the significant impact of the Covid-19 pandemic. The Group responded quickly to the challenges taking swift action to protect staff, reduce costs, optimise cash flow and protect liquidity. All divisions of the Group were affected to varying degrees by the pandemic. Since the half year, trading has improved, and the restructuring program is now complete.

In January 2021, the TFP division acquired PV3 Technologies Limited, a company specialising in the development and manufacture of electrochemical materials used in the creation of hydrogen. The acquisition is the latest step in TFP's growth plans, providing the opportunity to further enhance TFP's market position in the hydrogen economy. Following the suspension of all major capital expenditure in H1 due to the pandemic, work on installing the additional production line has now recommenced and is expected to be complete in summer of 2021.

Colourform's rate of growth has been impacted by a pandemic related downturn within the beauty and spirit sectors. Nonetheless, it is expected that revenues will be up on the previous year.

The Paper division endured the biggest impact from the pandemic as a result of global lockdowns affecting demand for luxury packaging, education and event collateral. In the first half, revenues were 45% down, compared to the comparable period last year, with the reduced demand leading to periods of inefficient or no production. Revenues in H2 have improved but expected to be 20% down compared to the comparable period last year.

The Company acted promptly at the start of the pandemic to conserve cash and implement immediate savings. It has good headroom against all its banking covenants and is in a strong financial position with liquidity of over £18 million from cash, overdraft and other available facilities including a £4m loan from the Coronavirus Large Business Interruption Loan Scheme. This is expected to be sufficient for the Company to return to more normal trading conditions, to invest and to emerge from the pandemic stronger.

Due to the improving trading performance and continued operational focus the Board expects the results for the year ending 27 March 2021 to be improved from previous expectations. The profit for the year ending 27 March 2021, before exceptional costs, is expected to be above £3.5m on sales of around £77m. This is an improvement from previous market expectations and includes around £2.9m of the Coronavirus Job Retention Scheme and Paycheck Protection Program government schemes.

This announcement contains information that would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

 

For further enquiries, please contact:

James Cropper PLC (AIM: CRPR)

Phil Wild, CEO

Isabelle Maddock, CFO

Tel: +44 (0) 1539 722002

www.jamescropper.com

 

 

Shore Capital

Robert Finlay, Henry Willcocks

John More

Tel: + 44 (0) 207 408 4050

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKPBDCBKDCNK
Date   Source Headline
7th Jan 200811:55 amRNSDirector/PDMR Shareholding
21st Dec 20072:14 pmRNSHolding(s) in Company
20th Dec 20073:20 pmRNSHolding(s) in Company
30th Nov 20079:10 amRNSHolding(s) in Company
27th Nov 20072:45 pmRNSHolding(s) in Company
20th Nov 20077:30 amRNSInterim Results
5th Nov 20077:00 amRNSNotice of Results
4th Oct 20073:20 pmRNSHolding(s) in Company
10th Sep 20072:21 pmRNSHolding(s) in Company
31st Aug 20078:00 amRNSCancellation - Cropper(James)
20th Aug 20074:10 pmRNSSch 1 Update -James Cropper
17th Aug 20074:36 pmRNSHolding(s) in Company
1st Aug 20072:46 pmRNSSchedule 1 -James Cropper plc
1st Aug 200712:10 pmRNSAGM and EGM Results
1st Aug 200710:48 amRNSAGM and IMS
31st Jul 200711:34 amRNSHolding(s) in Company
20th Jul 20072:54 pmRNSAnnual Information Update
20th Jul 20072:43 pmRNSSale of Pension Scheme Shares
10th Jul 20074:22 pmRNSChange of Shareholding
9th Jul 20074:59 pmRNSCircular re-transfer to AIM
29th Jun 20075:06 pmRNSHolding(s) in Company
19th Jun 20077:30 amRNSFinal Results
6th Jun 200710:49 amRNSTotal Voting Rights
24th May 20079:43 amRNSTrading Update
18th May 20077:00 amRNSNotice of Results
1st May 200711:47 amRNSChange of Adviser
21st Mar 20076:13 pmRNSHolding(s) in Company
15th Mar 20074:11 pmRNSHolding(s) in Company
7th Feb 20071:07 pmRNSIssue of Equity - Replacement
2nd Feb 20078:35 amRNSBlock Listing
1st Feb 20077:30 amRNSTrading Statement
11th Dec 20064:34 pmRNSVoting Rights and Capital
21st Nov 20067:30 amRNSInterim Results
6th Nov 20069:49 amRNSNotice of Results
25th Oct 200610:13 amRNSMain Board Appointment
18th Jul 20063:21 pmRNSAnnual Information Update
4th Jul 200610:16 amRNSHolding(s) in Company
20th Jun 20067:30 amRNSFinal Results
19th May 20067:00 amRNSNotice of Results
4th May 20069:13 amRNSHolding(s) in Company
7th Mar 20069:55 amRNSDirector/PDMR Shareholding
21st Dec 20055:27 pmRNSHolding(s) in Company
20th Dec 20059:20 amRNSDirector/PDMR Shareholding
6th Dec 20058:25 amRNSHolding(s) in Company
22nd Nov 20057:30 amRNSInterim Results
7th Nov 20057:00 amRNSNotice of Results
10th Aug 20059:18 amRNSAnnual Information Update
8th Aug 200512:10 pmRNSHolding(s) in Company
5th Aug 20054:07 pmRNSHolding(s) in Company
5th Aug 20054:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.